---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-113484"
form_type: "8-K"
ticker: "HRMY"
cik: "0001802665"
company_name: "Harmony Biosciences Holdings, Inc."
filed_at: "2024-11-01T23:59:59+00:00"
generated_at: "2026-05-30T07:02:04.718480+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Secondary offering of 8M shares by certain shareholders; company receives no proceeds

## Summary
- Selling Shareholders sold 8,000,000 shares of common stock in a registered public offering.
- Underwriters granted a 30-day option to purchase up to 1,200,000 additional shares.
- J.P. Morgan Securities LLC acted as the sole underwriter for the offering.
- Company will not receive any proceeds from the sale; all net proceeds go to Selling Shareholders.
- Offering closed on November 1, 2024, under an Underwriting Agreement dated October 30, 2024.

## SEC filing metadata
- accession: 0001104659-24-113484
- form_type: 8-K
- ticker: HRMY
- cik: 0001802665
- company_name: Harmony Biosciences Holdings, Inc.
- filed_at: 2024-11-01T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1802665/000110465924113484/0001104659-24-113484-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1802665/000110465924113484/tm2427273d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-113484
- JSON: https://secwatch.observer/filing/0001104659-24-113484.json
- Plain text: https://secwatch.observer/filing/0001104659-24-113484.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.